New Frontiers Meeting 2023: Psychedelics

Last chance to apply

This meeting will be held from 19-20 March 2023 in Nice, France, and by livestream.
Bringing together a unique mix of scientists, industry leaders, patient representatives and regulators, the meeting will explore the molecular mechanisms and pharmacology of psychedelics, while looking at neuroimaging, psychological variables, clinical trials, regulatory requirements, and the patient experience to map out critical research horizons and understand how to move these compounds forward as therapeutic agents.
Check the programme and apply by 14 December at 17.00 CET — Central European Time. There is no fee to attend.

ECNP Awards

Call for nominations

Nominate a candidate for:

• ECNP Neuropsychopharmacology Award which recognises exceptional research achievements in applied and translational neuroscience.
• ECNP Lifetime Achievement Award which celebrates outstanding career-long contributions to building the field of applied and translational neuroscience.
• ECNP Rising Star Award which honours up to three emerging research leaders in applied and translational neuroscience.

Deadline is 15 February 2023 at 23.59 CET — Central European Time.

36th ECNP Congress 2023

Invitation to industry

ECNP invites companies and organisations involved in clinical and pre-clinical research into, and diagnosis and treatment of disorders of the brain to contribute to the congress’s educational function. We have several opportunities:

• Industry sessions (application deadline is 18 January 2023)
• Exhibition (initial application deadline is 18 January 2023)
• Group registration (will open on 18 January 2023)
• Group hotel reservation

Neuroscience Applied

New open access articles

Check out the latest articles in Neuroscience Applied. All are open access and free to download.

• Polymorphisms in the adrenergic neurotransmission pathway impact antidepressant response in depressed patients
Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Diana Z. Paderina, ... Svetlana A. Ivanova

• Peripheral inflammatory effects of different interventions for treatment-resistant depression: A systematic review
Rebecca Strawbridge, Estefany Izurieta, Elana Day, Helena Tee, ... Anthony J. Cleare

• Common changes in rat cortical gene expression after chronic treatment with chlorpromazine and haloperidol may be related to their antipsychotic efficacy
Brian Dean, Elizabeth Scarr

• Associations between sleep quality and biomarkers for neurodegeneration - A longitudinal one-year case-control study of patients with bipolar disorder and healthy control individuals
Ulla Knorr, Anja Hviid Simonsen, Eva Letty Susanne Engström, Henrik Zetterberg, ... Lars Vedel Kessing

ECNP Public Choice Poster Award

Meet the winner 2022

We are pleased to announce that Sen Meltem, Turkey, is the winner of the ECNP Public Choice Poster Award! Her poster P.0831 'Altered volumes of the amygdala and hippocampus in the suicidal brain of patients with first episode psychosis' has been chosen by congress participants as the best poster presented at the 35^th ECNP Congress 2022. Congratulations!